7/30/2019 | CVLM | Array BioPharma holders may convert, put 2.625% notes due to merger
|
2/6/2018 | CV | Market Commentary: Convertibles trading volume light amid equity market volatility; Array, Lumentum gain
|
2/6/2018 | CV | Market Commentary: Morning Commentary: Convertibles trading volume light amid equity market volatility
|
12/22/2017 | CV | Market Commentary: Cobalt trading frenzy goes on; Array jumps up; WWE smacked down; EZCorp strengthens
|
12/4/2017 | CVLM | Array calls last $6.2 million 3% convertibles due 2020 for redemption
|
11/22/2017 | CV | Market Commentary: High trade volume for Intel continues; Everbridge, Square, Array make gains
|
11/21/2017 | CV | Market Commentary: Palo Alto jumps on earnings report, Array BioPharma’s new notes gain steam, Tesla active
|
11/20/2017 | CVLM | Array BioPharma avoids equity dilution with upsized exchange agreement
|
11/20/2017 | CVLM | Array to swap $19 million more 2020 convertibles for stock, new notes
|
11/20/2017 | CV | Market Commentary: Intel continues to dominate trading, Array BioPharma upsizes exchange agreement
|
11/16/2017 | CVLM | Array to swap $107 million of 2020 convertibles for stock, new notes
|
9/27/2016 | CV | Market Commentary: Array BioPharma surges again in active trade; Great Plains, Goldman Sachs BDC launch deals
|
9/27/2016 | CV | Market Commentary: Morning Commentary: Array BioPharma surges again in active trade; Priceline bonds slip
|
9/2/2016 | PP | Array BioPharma raises $10 million from placement of 5% convertibles
|
8/22/2016 | PP | Market Commentary: Biotech names eyed after Medivation takeout news; BioMarin convertibles add with shares
|
8/22/2016 | CV | Market Commentary: Biotech names eyed after Medivation takeout news; BioMarin convertibles add with shares
|
5/31/2016 | PP | Market Commentary: Health care in focus as sector lifts; Softbank mandatory exchangeable into Alibaba on tap
|
5/31/2016 | CV | Market Commentary: Health care in focus as sector lifts; Softbank mandatory exchangeable into Alibaba on tap
|
5/31/2016 | CV | Market Commentary: Morning Commentary: Health care in focus as sector lifts following Celator acquisition news
|
11/4/2015 | PP | Market Commentary: Tesla convertibles flat after earnings miss; Anthem adds on swap; FireEye contracts
|
11/4/2015 | CV | Market Commentary: Tesla convertibles flat after earnings miss; Anthem adds on swap; FireEye contracts
|
11/4/2015 | CV | Market Commentary: Morning Commentary: Convertibles primary remains quiet; Tesla Motors adds after earnings miss
|
1/26/2015 | PP | Market Commentary: FXCM strengthens; Molycorp adds; Array up; convertibles mostly quiet ahead of Nor’easter
|
1/26/2015 | CV | Market Commentary: FXCM strengthens; Molycorp adds; Array up; convertibles mostly quiet ahead of Nor’easter
|
1/23/2015 | PP | Market Commentary: Priceline active; FXCM better despite lower shares; Array BioPharma surges on drug deal
|
1/23/2015 | CV | Market Commentary: Priceline active; FXCM better despite lower shares; Array BioPharma surges on drug deal
|
6/7/2013 | CV | Array BioPharma greenshoe ups 3% convertibles deal to $132.25 million
|
6/6/2013 | CV | Market Commentary: Planned Jarden looks fair to rich; existing Jarden slips on swap; market seen quiet, weak
|
6/5/2013 | CV | New Issue: Array BioPharma sells upsized $115 million seven-year convertibles at 3%, up 32.5%
|
6/5/2013 | CV | Market Commentary: Array adds a point in busy debut; market weaker; DDR off 0.25 point; Prologis in 0.5 point
|
6/4/2013 | CV | Market Commentary: New Dominions trade around reoffered price and lower; planned Array note valuations eyed
|
6/3/2013 | CV | Array BioPharma to sell $100 million seven-year convertibles to yield 3%-3.5%, up 27.5%-32.5%
|
6/3/2013 | CV | Market Commentary: Dominion seen in gray near reoffer price; convertibles mostly quiet, better sellers seen
|
12/21/2012 | HYPF | Array BioPharma files $200 million shelf for stock, debt, preferreds
|
11/9/2012 | PP | Array BioPharma prices $65.7 million public sale of its stock at $3.65
|
11/8/2012 | PP | Array BioPharma aims to price public sale of its stock with greenshoe
|
2/14/2012 | PP | Array BioPharma wraps $59.8 million public offering of common stock
|
2/8/2012 | PP | Array BioPharma to price public offering of stock with greenshoe
|
11/23/2011 | CVHYPF | Array BioPharma files $150 million shelf for stock and preferreds
|
5/3/2011 | PP | Array BioPharm heralds $30 million convertible preferreds placement
|
5/2/2011 | PP | Array BioPharma to pay down loan facility with preferreds issuance
|
9/21/2009 | SS | Array Biopharma shareholder Kopp Investment reports 6.2% stake
|
8/3/2009 | SS | Array Biopharma shareholder Kopp Investment reports 5.2% stake
|
5/19/2009 | PP | New Issue: Array Biopharma concludes $40 million loan accompanied by warrants with Deerfield
|
11/7/2008 | CVHY | Array Biopharma files $150 million shelf registration
|
5/5/2008 | PP | New Issue: Array Biopharma orchestrates $80 million loan with Deerfield
|
11/6/2006 | BT | Array ups R&D spending by $2.2 million for first quarter of fiscal 2007
|
10/6/2006 | BTCV | Array Biopharma files $150 million stock, warrant shelf
|
9/14/2006 | BT | Array BioPharma gets $3 million milestone from AstraZeneca
|
6/27/2006 | BT | Array says it will enter new research partnership by end of year
|
6/22/2006 | BT | Array BioPharma gains from $32 million real estate transaction
|
6/8/2006 | BT | AstraZeneca, Array begin phase 2 studies of melanoma treatment
|
4/26/2006 | BT | Array BioPharma begins phase 1 trial of MEK inhibitor for inflammatory disease
|
4/17/2006 | BT | Array BioPharma achieves research milestone in Genentech collaboration
|
4/10/2006 | BT | Array BioPharma to receive $1 million milestone payment from AstraZeneca
|
1/24/2006 | BT | Array BioPharma gets $1 million milestone payment from AstraZeneca for MEK work
|
1/17/2006 | BT | Array BioPharma begins phase 1 trial for cancer drug ARRY-334543
|
10/13/2005 | BT | Array BioPharma, Genentech expand oncology collaboration
|
7/5/2005 | BT | Array BioPharma obtains $10 million term loan, $5 million equipment advances, $2 million revolver
|